2026-01-18 - Analysis Report
**Financial Report**
====================

**1. Company Overview**
------------------------

International Business Machines Corp.

**2. Return Rate Comparison**
-----------------------------

* Cumulative return of review stock: 130.94%
* Cumulative return of comparison stock (S&P 500, VOO): 93.36%
* Divergence: 37.60%
* Relative divergence: 83.90%

**3. Recent Stock Price Fluctuations**
-------------------------------------

* Current stock price: $305.67
* 5-day SMA: $305.60
* 20-day SMA: $302.11
* 60-day SMA: $303.84

**4. Analysis of RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**
---------------------------------------------------------------------------

* Market Risk Indicator (MRI): 0.80 (High Investment Recommended)
* RSI: 50.36
* PPO: 0.12
* Hybrid Signal: Buy
* Risk Level: Medium
* Relative divergence change (20 days): improving (+1.50)
* 7-day Rank change: flat (0)
* 7-day Dynamic Expected Return change: flat (0.00%)

**5. Recent News & Significant Events**
--------------------------------------

* 3 Reasons to Buy IBM Stock Right Now - The Motley Fool
* Bank of America resets IBM price target before earnings - Yahoo Finance Singapore
* IBM Stock Upgraded To Buy While Oracle Seen Bouncing Back In Analyst's 2026 Software Preview - Investor's Business Daily
* IBM Stock Had a Good 2025. It’s This Analyst’s Top Pick for 2026. - Barron's
* International Business Machines (NYSE:IBM) Stock Price Down 3.6% - Should You Sell? - MarketBeat
* The Bull Case For International Business Machines (IBM) Could Change Following Jefferies’ AI-Focused Upgrade - Yahoo Finance

**6. Analyst Opinions**
----------------------

Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
* Opinions: 19
* Target Price (avg/high/low): 302.05 / 375.00 / 198.00

**7. Recent Earnings Analysis**
-------------------------------

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-23 | 1.87 | $16.33B |
| 2025-07-24 | 2.36 | $16.98B |
| 2025-04-24 | 1.14 | $14.54B |
| 2024-10-30 | -0.36 | $14.97B |

**8. Financial Information**
---------------------------

### Revenue and Profitability:
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

### Capital and Profitability:
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

**Comprehensive Analysis (Summary)**
--------------------------------------

* The company has demonstrated a significant cumulative return of 130.94%, outperforming the S&P 500.
* Recent stock price fluctuations show a stable trend, with a 5-day SMA of $305.60 and a 60-day SMA of $303.84.
* Market Risk Indicator (MRI) is at 0.80, recommending high investment.
* Analysts have a positive consensus, with a mean rating of 2.38 (~Buy) and a target price of $302.05.
* Revenue and profitability have shown a strong trend, with a profit margin of 57.31% and 58.77% in the last two quarters.
* Capital and profitability have also improved, with a ROE of 6.25% and 7.98% in the last two quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.